Skip to main content

Table 3 Logistic regression analysis for clinical and pathological response

From: Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy

 

Clinical response

Pathological response

Factors

OR

95 % CI

p

OR

95 % CI

p

ER

0.76

0.077–7.6

0.81

0.56

0.03–6.2

0.65

PR

1.43

0.24–9.8

0.7

0.52

0.05–3.6

0.52

Ki-67 LI (hot spot)

1.0

0.15–6.5

0.98

2.1

0.26–25

0.49

Stromal beclin 1 (− vs +)

6.0

 

0.01

140000

 

0.0013